Opportunity
Simpler Grants.gov #HT942526ATRPTRA
Translational Arthritis Research Grant for Preclinical Studies (Army/DHA)
Buyer
U.S. Army Medical Research Acquisition Activity
Posted
May 01, 2026
Respond By
October 22, 2026
Identifier
HT942526ATRPTRA
NAICS
541715
This opportunity invites applications for a translational arthritis research grant managed by the US Army Medical Research Acquisition Activity (USAMRAA) and the Defense Health Agency (DHA). - Government Buyer: - US Army Medical Research Acquisition Activity (USAMRAA) - Defense Health Agency (DHA), including Congressionally Directed Medical Research Programs (CDMRP) and Defense Health Agency Research and Development (DHA R&D) - OEMs and Vendors: - No specific OEMs or vendors are named; this is a research grant, not a product procurement - Products/Services Requested: - Translational arthritis research (preclinical/animal studies only) - Focus on high-impact, hypothesis-driven research relevant to Service Members, Veterans, their Families, and the American public - Research addressing all types of arthritis, including osteoarthritis and post-traumatic arthritis - Applicants must provide preliminary and/or published data - Unique/Notable Requirements: - Only preclinical or animal research is eligible; clinical research, clinical trials, and basic research are excluded - Emphasis on accelerating findings into clinically relevant solutions - Total funding available is approximately $1.6 million, with up to two awards expected - Maximum period of performance is three years - Place of Performance/Delivery: - Military Health System and related federal facilities
Description
The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Translational Research Award (TRA) supports high-impact translational research aimed at accelerating critical findings into clinically relevant solutions. The research must be hypothesis-driven and relevant to Service Members, Veterans, their Families, and the American public, addressing any and all types of arthritis. This award supports preclinical or animal research and excludes clinical research, clinical trials, and basic research. Preliminary and/or published data from the applicant or others is required.